Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Cervical determinants of anal HPV infection and high-grade anal lesions in women: a collaborative pooled analysis.

Lin C, Slama J, Gonzalez P, Goodman MT, Xia N, Kreimer AR, Wu T, Hessol NA, Shvetsov Y, Ortiz AP, Grinsztejn B, Moscicki AB, Heard I, Del Refugio González Losa M, Kojic EM, Schim van der Loeff MF, Wei F, Longatto-Filho A, Mbulawa ZA, Palefsky JM, Sohn AH, Hernandez BY, Robison K, Simpson S Jr, Conley LJ, de Pokomandy A, van der Sande MAB, Dube Mandishora RS, Volpini LPB, Pierangeli A, Romero B, Wilkin T, Franceschi S, Hidalgo-Tenorio C, Ramautarsing RA, Park IU, Tso FK, Godbole S, D'Hauwers KWM, Sehnal B, Menezes LJ, Heráclio SA, Clifford GM.

Lancet Infect Dis. 2019 Aug;19(8):880-891. doi: 10.1016/S1473-3099(19)30164-1. Epub 2019 Jun 13.

2.

Estimated Number of Cases of High-Grade Cervical Lesions Diagnosed Among Women - United States, 2008 and 2016.

McClung NM, Gargano JW, Park IU, Whitney E, Abdullah N, Ehlers S, Bennett NM, Scahill M, Niccolai LM, Brackney M, Griffin MR, Pemmaraju M, Querec TD, Cleveland AA, Unger ER, Markowitz LE; HPV-IMPACT Working Group.

MMWR Morb Mortal Wkly Rep. 2019 Apr 19;68(15):337-343. doi: 10.15585/mmwr.mm6815a1.

3.

Trends in anogenital wart incidence among Tennessee Medicaid enrollees, 2006-2014: The impact of human papillomavirus vaccination.

Shing JZ, Hull PC, Zhu Y, Gargano JW, Markowitz LE, Cleveland AA, Pemmaraju M, Park IU, Whitney E, Mitchel EF, Griffin MR.

Papillomavirus Res. 2019 Jun;7:141-149. doi: 10.1016/j.pvr.2019.04.007. Epub 2019 Apr 10.

4.

Cervical adenocarcinoma in situ: Human papillomavirus types and incidence trends in five states, 2008-2015.

Cleveland AA, Gargano JW, Park IU, Griffin MR, Niccolai LM, Powell M, Bennett NM, Saadeh K, Pemmaraju M, Higgins K, Ehlers S, Scahill M, Johnson Jones ML, Querec T, Markowitz LE, Unger ER; HPV-IMPACT Working Group.

Int J Cancer. 2019 Apr 13. doi: 10.1002/ijc.32340. [Epub ahead of print]

PMID:
30980692
5.

Trends in Human Papillomavirus Vaccine Types 16 and 18 in Cervical Precancers, 2008-2014.

McClung NM, Gargano JW, Bennett NM, Niccolai LM, Abdullah N, Griffin MR, Park IU, Cleveland AA, Querec TD, Unger ER, Markowitz LE; HPV-IMPACT Working Group.

Cancer Epidemiol Biomarkers Prev. 2019 Mar;28(3):602-609. doi: 10.1158/1055-9965.EPI-18-0885. Epub 2019 Feb 21.

PMID:
30792242
6.

Performance of the Syphilis Health Check in Clinic and Laboratory-Based Settings.

Fakile YF, Brinson M, Mobley V, Park IU, Gaynor AM.

Sex Transm Dis. 2019 Apr;46(4):250-253. doi: 10.1097/OLQ.0000000000000974.

7.

Trends in High-grade Cervical Lesions and Cervical Cancer Screening in 5 States, 2008-2015.

Gargano JW, Park IU, Griffin MR, Niccolai LM, Powell M, Bennett NM, Johnson Jones ML, Whitney E, Pemmaraju M, Brackney M, Abdullah N, Scahill M, Dahl RM, Cleveland AA, Unger ER, Markowitz LE; HPV-IMPACT Working Group .

Clin Infect Dis. 2019 Apr 8;68(8):1282-1291. doi: 10.1093/cid/ciy707.

PMID:
30137283
8.

Performance of Treponemal Tests for the Diagnosis of Syphilis.

Park IU, Fakile YF, Chow JM, Gustafson KJ, Jost H, Schapiro JM, Novak-Weekley S, Tran A, Nomura JH, Chen V, Beheshti M, Tsai T, Hoover K, Bolan G.

Clin Infect Dis. 2019 Mar 5;68(6):913-918. doi: 10.1093/cid/ciy558.

PMID:
29986091
9.

Correlation of Treponemal Immunoassay Signal Strength Values with Reactivity of Confirmatory Treponemal Testing.

Fakile YF, Jost H, Hoover KW, Gustafson KJ, Novak-Weekley SM, Schapiro JM, Tran A, Chow JM, Park IU.

J Clin Microbiol. 2017 Dec 26;56(1). pii: e01165-17. doi: 10.1128/JCM.01165-17. Print 2018 Jan.

10.

A Case of Persistent and Possibly Treatment Resistant Pharyngeal Gonorrhea.

Levy V, Pandori M, Berrada ZL, Relucio KI, Lopez TP, Samuel MC, Park IU.

Sex Transm Dis. 2016 Apr;43(4):258-9. doi: 10.1097/OLQ.0000000000000430.

PMID:
26967304
11.

Interventions to Improve Sexually Transmitted Disease Screening in Clinic-Based Settings.

Taylor MM, Frasure-Williams J, Burnett P, Park IU.

Sex Transm Dis. 2016 Feb;43(2 Suppl 1):S28-41. doi: 10.1097/OLQ.0000000000000294. Review.

12.

Human Papillomavirus and Genital Warts: A Review of the Evidence for the 2015 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines.

Park IU, Introcaso C, Dunne EF.

Clin Infect Dis. 2015 Dec 15;61 Suppl 8:S849-55. doi: 10.1093/cid/civ813. Review.

PMID:
26602622
13.

Improvement of Sexually Transmitted Disease Screening Among HIV-Infected Men Who Have Sex With Men Through Implementation of a Standardized Sexual Risk Assessment Tool.

Scarborough AP, Slome S, Hurley LB, Park IU.

Sex Transm Dis. 2015 Oct;42(10):595-8. doi: 10.1097/OLQ.0000000000000333.

PMID:
26372932
14.

Monitoring Effect of Human Papillomavirus Vaccines in US Population, Emerging Infections Program, 2008-2012.

Hariri S, Markowitz LE, Bennett NM, Niccolai LM, Schafer S, Bloch K, Park IU, Scahill MW, Julian P, Abdullah N, Levine D, Whitney E, Unger ER, Steinau M, Bauer HM, Meek J, Hadler J, Sosa L, Powell SE, Johnson ML; Hpv-Impact Working Group.

Emerg Infect Dis. 2015 Sep;21(9):1557-61. doi: 10.3201/eid2109.141841.

15.

Population-based trends in high-grade cervical lesions in the early human papillomavirus vaccine era in the United States.

Hariri S, Johnson ML, Bennett NM, Bauer HM, Park IU, Schafer S, Niccolai LM, Unger ER, Markowitz LE; HPV-IMPACT Working Group.

Cancer. 2015 Aug 15;121(16):2775-81. doi: 10.1002/cncr.29266. Epub 2015 Jun 22.

16.

Discordant Syphilis Immunoassays in Pregnancy: Perinatal Outcomes and Implications for Clinical Management.

Mmeje O, Chow JM, Davidson L, Shieh J, Schapiro JM, Park IU.

Clin Infect Dis. 2015 Oct 1;61(7):1049-53. doi: 10.1093/cid/civ445. Epub 2015 Jun 10.

17.

Cytology and human papillomavirus co-test results preceding incident high-grade cervical intraepithelial neoplasia.

Park IU, Wojtal N, Silverberg MJ, Bauer HM, Hurley LB, Manos MM.

PLoS One. 2015 Mar 20;10(3):e0118938. doi: 10.1371/journal.pone.0118938. eCollection 2015.

18.

Reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States - 2008-2012.

Hariri S, Bennett NM, Niccolai LM, Schafer S, Park IU, Bloch KC, Unger ER, Whitney E, Julian P, Scahill MW, Abdullah N, Levine D, Johnson ML, Steinau M, Markowitz LE; HPV-IMPACT Working Group.

Vaccine. 2015 Mar 24;33(13):1608-13. doi: 10.1016/j.vaccine.2015.01.084. Epub 2015 Feb 11.

PMID:
25681664
19.

HPV type attribution in high-grade cervical lesions: assessing the potential benefits of vaccines in a population-based evaluation in the United States.

Hariri S, Unger ER, Schafer S, Niccolai LM, Park IU, Bloch KC, Bennett NM, Steinau M, Johnson ML, Markowitz LE; HPV-IMPACT Working Group.

Cancer Epidemiol Biomarkers Prev. 2015 Feb;24(2):393-9. doi: 10.1158/1055-9965.EPI-14-0649. Epub 2014 Nov 21.

20.

Modelling the effects of subjective and objective decision making in scientific peer review.

Park IU, Peacey MW, Munafò MR.

Nature. 2014 Feb 6;506(7486):93-6. doi: 10.1038/nature12786. Epub 2013 Dec 4.

PMID:
24305052
21.

HPV and HPV-associated diseases.

Dunne EF, Park IU.

Infect Dis Clin North Am. 2013 Dec;27(4):765-78. doi: 10.1016/j.idc.2013.09.001. Review.

PMID:
24275269
22.

A systematic review of randomized trials assessing human papillomavirus testing in cervical cancer screening.

Patanwala IY, Bauer HM, Miyamoto J, Park IU, Huchko MJ, Smith-McCune KK.

Am J Obstet Gynecol. 2013 May;208(5):343-53. doi: 10.1016/j.ajog.2012.11.013. Epub 2012 Nov 15. Review.

23.

Patient-delivered partner therapy for chlamydial infections: practices, attitudes, and knowledge of california family planning providers.

Jotblad S, Park IU, Bauer HM, Barandas A, Deal M, Amey A.

Sex Transm Dis. 2012 Feb;39(2):122-7. doi: 10.1097/OLQ.0b013e318237b723.

PMID:
22249301
24.

Screening for syphilis with the treponemal immunoassay: analysis of discordant serology results and implications for clinical management.

Park IU, Chow JM, Bolan G, Stanley M, Shieh J, Schapiro JM.

J Infect Dis. 2011 Nov;204(9):1297-304. doi: 10.1093/infdis/jir524. Epub 2011 Sep 19.

PMID:
21930610
25.

Retesting for repeat chlamydial infection: family planning provider knowledge, attitudes, and practices.

Park IU, Amey A, Creegan L, Barandas A, Bauer HM.

J Womens Health (Larchmt). 2010 Jun;19(6):1139-44. doi: 10.1089/jwh.2009.1648.

PMID:
20482236
26.

Evaluation and Management of Anal Intraepithelial Neoplasia in HIV-Negative and HIV-Positive Men Who Have Sex with Men.

Park IU, Palefsky JM.

Curr Infect Dis Rep. 2010 Mar;12(2):126-33. doi: 10.1007/s11908-010-0090-7. Epub 2010 Feb 24.

27.

Anal human papillomavirus infection and abnormal anal cytology in women with genital neoplasia.

Park IU, Ogilvie JW Jr, Anderson KE, Li ZZ, Darrah L, Madoff R, Downs L Jr.

Gynecol Oncol. 2009 Sep;114(3):399-403. doi: 10.1016/j.ygyno.2009.05.008. Epub 2009 Jun 6.

PMID:
19501896
28.

Anal dysplasia in kidney transplant recipients.

Ogilvie JW Jr, Park IU, Downs LS, Anderson KE, Hansberger J, Madoff RD.

J Am Coll Surg. 2008 Dec;207(6):914-21. doi: 10.1016/j.jamcollsurg.2008.08.005. Epub 2008 Sep 30.

PMID:
19183539
29.

Cervical cancer prevention in the developing world.

Park IU, Diaz ML, Bowey C, Magaril R, Ferris DG; INCCA Foundation.

J Low Genit Tract Dis. 2007 Oct;11(4):273. No abstract available.

PMID:
17917572
30.
31.

An assessment of the severity of recurrent appendicitis.

Dixon MR, Haukoos JS, Park IU, Oliak D, Kumar RR, Arnell TD, Stamos MJ.

Am J Surg. 2003 Dec;186(6):718-22; discussion 722.

PMID:
14672785
32.

Correlates of HIV risk among Ecuadorian adolescents.

Park IU, Sneed CD, Morisky DE, Alvear S, Hearst N.

AIDS Educ Prev. 2002 Feb;14(1):73-83.

PMID:
11900112

Supplemental Content

Support Center